BIOMAT Database Logo BIOMAT Database Logo

Deficient natural killer (NK) cell activity in paroxysmal nocturnal haemoglobinuria (PNH). 1982

Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006457 Hemoglobinuria, Paroxysmal A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins. Paroxysmal Cold Hemoglobinuria,Paroxysmal Nocturnal Hemoglobinuria,Marchiafava-Micheli Syndrome,Paroxysmal Hemoglobinuria,Paroxysmal Hemoglobinuria, Cold,Paroxysmal Hemoglobinuria, Nocturnal,Cold Paroxysmal Hemoglobinuria,Hemoglobinuria, Cold Paroxysmal,Hemoglobinuria, Nocturnal Paroxysmal,Hemoglobinuria, Paroxysmal Cold,Hemoglobinuria, Paroxysmal Nocturnal,Marchiafava Micheli Syndrome,Nocturnal Paroxysmal Hemoglobinuria,Syndrome, Marchiafava-Micheli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
A case of paroxysmal nocturnal haemoglobinuria (PNH).
June 1987, The Medical journal of Malaysia,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
[Paroxysmal nocturnal haemoglobinuria (PNH) and pregnancy (author's transl)].
August 1980, Geburtshilfe und Frauenheilkunde,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
The laboratory substitutes of the red cell of paroxysmal nocturnal haemoglobinuria (PNH): PNH-like red cells.
January 1972, Series haematologica (1968),
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients.
October 2012, Tissue antigens,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease.
November 2020, British journal of haematology,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
March 2024, British journal of haematology,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Studies of the role of red cell membrane peroxidation in paroxysmal nocturnal haemoglobinuria (PNH).
January 1974, British journal of haematology,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
July 1972, British journal of haematology,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Enhanced complement-susceptibility and dysfunction of lymphocytes in paroxysmal nocturnal haemoglobinuria (PNH).
December 1990, British journal of haematology,
Y Yoda, and T Abe, and K Mitamura, and K Saito, and K Kawada, and Y Onozawa, and Y Adachi, and T Nomura
Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH).
August 1989, British journal of haematology,
Copied contents to your clipboard!